A mid-stage clinical trial of CagriSema showed that when combining the two drugs, patients’ body weight was reduced ...
Most of us know someone that has been affected by diabetes. It can lead to severe health problems, such as eye problems, ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Rising numbers of people are needing hospital treatment for side effects from weight loss injections and it may be affecting ...
These drugs are collectively known as GLP-1 agonists because ... 37% of people using a GLP-1 drug for either diabetes or ...
Tirzepatide, known under the brand name Mounjaro is prescribed for type 2 diabetes, but has been shown in clinical trials to ...
Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...